6th Annual OPT Congress - Oligonucleotide & Precision Therapeutics

The 6th Annual OPT Congress - Oligonucleotide & Precision Therapeutics is a conference dedicated to the discovery, development and delivery of oligonucleotide and peptide therapeutics.

The 6th Annual OPT Congress - Oligonucleotide & Precision Therapeutics covers topics such as:

• Peptide discovery and delivery - next generation of targeted peptide therapeutics
• Oligonucleotide discovery and delivery - aptamer, antisense and rna therapeutics
• Drug discovery for rare diseases - genomic and proteomic targets and drug modalities

The 6th Annual OPT Congress - Oligonucleotide & Precision Therapeutics brings together executives, directors, managers, and scientists from Biotechs, Pharma, Government and Healthcare and Academia working in:

• Immunotherapy
• Oligonucleotide Therapeutics
• Gene Editing
• Gene Therapy
• Rare Diseases

The 6th Annual OPT Congress - Oligonucleotide & Precision Therapeutics will be held on 30-31 Mar 2021.